HOMEX-1: Home-based Exercise Training for COPD Patients

Sponsor
University of Zurich (Other)
Overall Status
Completed
CT.gov ID
NCT03461887
Collaborator
(none)
123
5
2
43.7
24.6
0.6

Study Details

Study Description

Brief Summary

The aim of this study is to assess the effectiveness of a home-based exercise training program in COPD patients who have completed a pulmonary rehabilitation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise
N/A

Detailed Description

Exercise training is an important component of the management of chronic obstructive pulmonary disease (COPD) and numerous trials have shown large improvements in health-related quality of life (HRQoL) and exercise capacity in persons with COPD. However, the great majority of patients who would benefit from pulmonary rehabilitation (PR) never follow such a program. Moreover, many COPD patients are either not instructed to exercise at all or fail to adhere to exercise training at home after completing pulmonary rehabilitation.

This study evaluates an exercise training program that requires minimal equipment (i.e., only a chair and elastic bands) and can be easily implemented long-term in the patient's home-setting.

Study Design

Study Type:
Interventional
Actual Enrollment :
123 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Effects of a Long-term Home-based Exercise Training Program Using Minimal Equipment vs. Usual Care in COPD Patients: a Multicenter Randomized Controlled Trial
Actual Study Start Date :
Jan 24, 2018
Actual Primary Completion Date :
Mar 20, 2020
Actual Study Completion Date :
Sep 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise intervention

Home-based, minimal equipment exercise training program.

Behavioral: Exercise
Home-based exercise training program that requires only minimal equipment, and is individually adaptable to the participant's exercise level (6 times per week; 15-20 min; 38 exercise cards and one interactive training agenda booklet). After randomization, a health care professional (HOMEX coach) will visit the intervention group participants at their home to set up the training location, to instruct the exercises and to establish individualized goals. Follow-up visits are planned after 3 and 8-9 weeks. Regular telephone calls will be conducted by the same HOMEX coach to motivate the patients, to discuss training progress and concrete benefits and barriers, and to adapt goals and the training program. Additional intervention elements are that a relative or friend is involved as a "sparring" partner to support the participant. The general practitioner is informed about the participation of his/her patient in the intervention.

No Intervention: Control

Usual care (study participation does not have any impact on regular treatment or treatment decisions, including participation in other exercise training programs or rehabilitation programs)

Outcome Measures

Primary Outcome Measures

  1. Dyspnea [Change from baseline to 12 months]

    Dyspnea domain of the Chronic Respiratory Questionnaire (CRQ); 5 questions; 7-point Likert-type scale ranging from 1 (most severe dyspnea) to 7 (no dyspnea)

Secondary Outcome Measures

  1. Dyspnea [Change from baseline to 3, 6 and 12 months]

    Dyspnea domain of the Chronic Respiratory Questionnaire (CRQ); 5 questions; 7-point Likert-type scale ranging from 1 (most severe dyspnea) to 7 (no dyspnea)

  2. Exercise capacity [Change from baseline to 12 months]

    Six-Minute Walk Test (walk distance) and 1-min Sit-to-Stand Test (number of repetitions)

  3. Health-related quality of life [Change from baseline to 12 months]

    Chronic Respiratory Questionnaires (CRQ): Fatigue, emotional function, mastery domain and EuroQoL (EQ-5D-5L): 5 Dimensions - Mobility, self-care, usual activities, pain/discomfort, anxiety/depression including 1 item each with 5 levels

  4. Health status [Change from baseline to 12 months]

    Visual analogue scale "Feeling thermometer" (0-100 scale; 0= "worst health you can imagine"; 100="best health you can imagine")

  5. Exacerbations [During entire study, assessed at 12 months]

    Event based, patient reported

  6. Symptoms [Change from baseline to 12 months]

    Questionnaire, COPD Assessment Test

Other Outcome Measures

  1. Compliance to the exercise training program [Assessed daily by intervention group participants during 12 months]

    Percentage of fulfilled training sessions based on training diaries

  2. Satisfaction with the exercise training program [From baseline to 12 months]

    Questionnaire (Likert-Type scales)

  3. Experience with the exercise training program [From baseline to 12 months (assessed at 12 months)]

    Semi-structured interview

  4. Health professionals' feedback [Assessed at 12 months]

    Semi-structured interview

  5. Cost effectiveness [From baseline to 12 months (assessed at 3, 6, 12 months)]

    Questionnaire: cost per quality-adjusted life year

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Signed informed consent after being informed

  • Diagnosis of COPD, defined as forced expiratory volume in 1s/forced vital capacity (FEV1/FVC)<70% predicted, FEV1<80 % predicted after bronchodilation, with or without chronic symptoms (cough, sputum production) corresponding to a GOLD stage II-IV

  • Completion of an inpatient or outpatient pulmonary rehabilitation not longer than 1 months ago

  • Male and female patients ≥40 years of age

  • Knowledge of German language to understand study material and assessments

Exclusion Criteria:
  • Patients not able to conduct the exercise training program due to physical, cognitive or safety reasons, as judged by investigator; e.g., lower limb joint surgery within preceding 3 months, unstable cardiac disease, predominant neurological limitations.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Klinik Barmelweid Barmelweid Switzerland 5017
2 Berner Reha Zentrum AG Heiligenschwendi Switzerland 3625
3 Zürcher RehaZentren Wald Wald Switzerland 8636
4 Kantonsspital Winterthur Winterthur Switzerland 8401
5 University of Zurich Zurich Switzerland 8001

Sponsors and Collaborators

  • University of Zurich

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Zurich
ClinicalTrials.gov Identifier:
NCT03461887
Other Study ID Numbers:
  • HOMEX-1
First Posted:
Mar 12, 2018
Last Update Posted:
Dec 27, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Zurich
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 27, 2021